Robert B Sargeant

Title: The Innovations of Robert B. Sargeant

Introduction

Robert B. Sargeant is an accomplished inventor based in Ramona, California. He has made significant contributions to the field of assay protocols, particularly through his innovative patent. His work focuses on enhancing the efficiency and effectiveness of specific binding pair assays, which are crucial in various scientific and medical applications.

Latest Patents

Sargeant holds a patent for "Lateral flow, non-bibulous membrane assay protocols." This invention describes a method and apparatus for conducting specific binding pair assays, such as immunoassays. The patent outlines the use of a porous membrane capable of non-bibulous lateral flow as the assay substrate. A member of the binding pair is affixed in an indicator zone defined in the substrate. The sample is applied at a position distant from the indicator zone and permitted to flow laterally through the zone. Any analyte in the sample is complexed by the affixed specific binding member and detected. A novel method of detection employs the entrapment of observable particles in the complex. Blood is a particularly preferred sample, as the red blood cells can be used as the observable particles for detection of the complex. Sargeant's innovative approach has the potential to improve diagnostic accuracy and efficiency.

Career Highlights

Robert B. Sargeant has dedicated his career to advancing the field of assay technology. He is currently associated with Quidel Corporation, where he continues to develop and refine his innovative methods. His work has garnered attention for its practical applications in medical diagnostics and research.

Collaborations

Sargeant has collaborated with notable colleagues, including Robert W. Eisinger and Mohammed H. Khalil. These partnerships have contributed to the development of cutting-edge technologies in the field of assays.

Conclusion

Robert B. Sargeant's contributions to assay protocols exemplify the impact of innovation in the medical and scientific communities. His patent for lateral flow assay methods showcases his commitment to improving diagnostic techniques. Through his work at Quidel Corporation and collaborations with esteemed colleagues, Sargeant continues to push the boundaries of what is possible in assay technology.